Objective: To review the place in therapy of vandetanib for medullary thyroid carcinoma (MTC).
Data Sources: Literature searches were performed in Ovid MEDLINE, EMBASE, and Google Scholar using the search terms ZD6474 OR vandetanib OR Caprelsa combined with medullary thyroid carcinoma.
Study Selection And Data Extraction: Two phase 2 trials and 1 phase 3 trial were identified.